ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

0.2669
Delayed Data
As of 4:15pm ET
 +0.0027 / +1.02%
Today’s Change
0.23
Today|||52-Week Range
1.96
-25.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.3K16.4K21.5K28.0K
 
 
 
 
 
 
Operating ExpensesGross Income-1.3K-16.4K-21.5K-28.0K
 
 
 
 
 
General Expenses1.7M13.9M20.6M21.0M
 
 
 
 
 
Research And Development314.2K8.4M15.0M13.7M
 
 
 
 
 
Total Operating Expenses1.7M14.0M20.6M21.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.7M-14.0M-20.6M-21.0M
 
 
 
 
 
Extraordinary Credit0.000.003.8M4.2M
 
 
 
Extraordinary Charge-3.6M-387.9K-214.0K0.00
 
 
 
 
Interest Expense On Debt12.9K0.00----
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.3M-14.3M-17.0M-16.8M
 
 
 
 
 
Income Taxes0.000.000.00-1.9M
 
 
Preferred Dividend0.00-7.8M0.000.00
 
 
Net Income-5.3M-14.3M-17.0M-14.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.8M21.8M27.1M58.3M
 
 
 
 
 
Shares To Calculate EPS Diluted12.8M21.8M27.1M58.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.41-$1.02-$0.63-$0.30
 
 
 
 
 
EPS Diluted-$0.41-$1.02-$0.63-$0.30